Cargando…
Successful rapid drug desensitization to methotrexate in a patient with primary central nervous system lymphoma
Autores principales: | Song, Kyung Mee, Lee, Junghwan, Park, Ji Hyun, Park, So-Young, Kim, Tae-Bum, Suh, Cheolwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898998/ https://www.ncbi.nlm.nih.gov/pubmed/29662865 http://dx.doi.org/10.5045/br.2018.53.1.71 |
Ejemplares similares
-
Beta-2 microglobulin as a prognostic factor of primary central nervous system lymphoma
por: Hyung, Jaewon, et al.
Publicado: (2019) -
Primary Histiocytic Sarcoma of the Central Nervous System
por: So, Hoonsub, et al.
Publicado: (2015) -
Successful rapid oral desensitization for dual hypersensitivity to isoniazid and rifampin while treating central nervous system tuberculosis
por: Roy, Moni, et al.
Publicado: (2018) -
Methotrexate, cytarabine, thiotepa and rituximab (MATRix) chemoimmunotherapy for primary central nervous system lymphoma: a Toronto experience
por: Suleman, Adam, et al.
Publicado: (2022) -
Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma
por: Kim, Jeong Eun, et al.
Publicado: (2012)